Researchers Identify Source of Inflammation and Tissue Damage in Chlamydia Infections
February 27th 2018The investigators concluded that 2 separate immune pathways are key players in the way in which the body deals with chlamydia: one pathway clears the bacteria, while another fuels inflammation and tissue damage.
Once-Daily Fixed-Dose HIV Combo Drug from Mylan NV Receives Tentative Approval from FDA
February 20th 2018Mylan NV's new drug application for its combo regimen of dolutegravir, emtricitabine, and tenofovir alafenamide, received tentative approval from the US Food and Drug Administration under the President's Emergency Plan for AIDS Relief (PEPFAR).